Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial-Reference-Cited by-同舟云学术

Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

Published:2023-02 Issue:14 Volume:18 Page:1197-1200
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Slagboom Ton,Toelg Ralph,Witzenbichler Bernhard,Haude Michael,Masotti Monica,Ruiz Salmeron Rafael,Witkowski Adam Ryszard,Uematus Masaaki,Takahashi Akihiko,Waksman Ron,Saito Shigeru

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent

2. BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

3. Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents

4. Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial

5. Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up;European Journal of Medical Research;2024-07-27

2. Pathological Mechanism of Neuronal Autophagy Flow Disturbance Caused by NSF ATPase Inactivation After Cerebral Ischemia;PROG BIOCHEM BIOPHYS;2024

3. Comparative Effectiveness of Ultrathin vs. Standard Strut Drug-Eluting Stents: Insights from a Large-Scale Meta-Analysis with Extended Follow-up;2024-04-01

4. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

5. High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data;Diagnostics;2023-04-02